CIK 0001860657 · <br>Emerging growth company
Allarity Therapeutics, Inc.
Sign in to watch- Ticker
- ALLR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 401-426-4664
- Business address
- 24 SCHOOL ST., 2ND FLOOR, BOSTON, MA, 02108
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Material agreement · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- PRER14A Other PRER14A
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
- SC 13G/A Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Agreement ended · Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
- S-1/A Offering Registration Statement
- 8-K Event Executive or director change · Other events
Page 9 of 21 · 403 filings